Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Waxman

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Gastroenterology|June 19, 2017
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular FeaturesDaniela Sia, Yang Jiao, Iris Martinez-Quetglas, et al.
Molecular Cancer Therapeutics|June 17, 2015
Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast CancerYeon-Jin Kwon, Kevin Petrie, Boris A Leibovitch, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2004
All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemiaZhi-Xiang Shen, Zhan-Zhong Shi, Jing Fang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2009
Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemiaJiong Hu, Yuan-Fang Liu, Chuan-Feng Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapyBai-Wei Gu, Hui Xiong, Yan Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2005
Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemiaPei-Zheng Zheng, Kan-Kan Wang, Qun-Ye Zhang, et al.
Nature Communications|January 23, 2015
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinomaDaniela Sia, Bojan Losic, Agrin Moeini, et al.
Gastroenterology|January 9, 2013
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomesDaniela Sia, Yujin Hoshida, Augusto Villanueva, et al.
Cancer Research|August 15, 2008
Focal gains of VEGFA and molecular classification of hepatocellular carcinomaDerek Y Chiang, Augusto Villanueva, Yujin Hoshida, et al.
Gastroenterology|October 22, 2008
Pivotal role of mTOR signaling in hepatocellular carcinomaAugusto Villanueva, Derek Y Chiang, Pippa Newell, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Gastroenterology|June 19, 2017
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular FeaturesDaniela Sia, Yang Jiao, Iris Martinez-Quetglas, et al.
Molecular Cancer Therapeutics|June 17, 2015
Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast CancerYeon-Jin Kwon, Kevin Petrie, Boris A Leibovitch, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2004
All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemiaZhi-Xiang Shen, Zhan-Zhong Shi, Jing Fang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2009
Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemiaJiong Hu, Yuan-Fang Liu, Chuan-Feng Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapyBai-Wei Gu, Hui Xiong, Yan Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2005
Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemiaPei-Zheng Zheng, Kan-Kan Wang, Qun-Ye Zhang, et al.
Nature Communications|January 23, 2015
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinomaDaniela Sia, Bojan Losic, Agrin Moeini, et al.
Gastroenterology|January 9, 2013
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomesDaniela Sia, Yujin Hoshida, Augusto Villanueva, et al.
Cancer Research|August 15, 2008
Focal gains of VEGFA and molecular classification of hepatocellular carcinomaDerek Y Chiang, Augusto Villanueva, Yujin Hoshida, et al.
Gastroenterology|October 22, 2008
Pivotal role of mTOR signaling in hepatocellular carcinomaAugusto Villanueva, Derek Y Chiang, Pippa Newell, et al.
Pageof 8